Tech Company Financing Transactions
WellTheory Funding Round
WellTheory, based in Atherton, secured $14 million in funding from General Catalyst, 7wire Ventures and Accel Partners.
Transaction Overview
Company Name
Announced On
10/15/2025
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
General Catalyst (Lead Investor) (Candace Richardson)
Proceeds Purpose
The company intends to use the funds to deepen partnerships with employers and payors, expand care programs targeting the fastest-growing cost centers in healthcare, and invest in AI-enabled personalization.
Company Information
Company Status
Private & Independent
Industry
EdTech
Mailing Address
68 Tuscaloosa Ave.
Atherton, CA 94027
USA
Atherton, CA 94027
USA
Phone
Website
Email Address
Overview
We're Building a World Where Autoimmune Care Is More Affordable -- and More Human. It's extremely difficult to find whole-body care that addresses the root cause of autoimmunity. At WellTheory, we're not about fast facts or quick fixes. Our care team will work with you to heal your system and address the root cause of your autoimmunity -- and make sure you feel heard, supported, and cared for along the way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Ellen Rudolph
Browse more venture capital transactions:
Prev: 10/15/2025: Vantaca venture capital transaction
Next: 10/15/2025: Ascribe Bioscience venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs